Patents by Inventor Linda S. Park

Linda S. Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090226472
    Abstract: Mammalian Interleukin-4 receptor proteins, DNAs and expression vectors encoding mammalian IL-4 receptors, and processes for producing mammalian IL-4 receptors as products of cell culture, are disclosed. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
    Type: Application
    Filed: November 20, 2007
    Publication date: September 10, 2009
    Inventors: Bruce A. Mosley, David J. Cosman, Linda S. Park, M. Patricia Beckmann, Carl J. March, Rejean Idzerda
  • Patent number: 7317090
    Abstract: Methods and comnositions related to antibodies that bind to mammalian Tnterleulcin-4 recentor proteins are disclosed.
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: January 8, 2008
    Assignee: Immunex Corporation
    Inventors: Bruce A. Mosley, David J. Cosman, Linda S. Park, M. Patricia Beckmann, Carl J. March, Rejean Idzerda
  • Patent number: 6716587
    Abstract: Mammalian Interleukin-4 receptor proteins, DNAs and expression vectors encoding mammalian IL-4 receptors, and processes for producing mammalian IL-4 receptors as products of cell culture, are disclosed. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: April 6, 2004
    Assignee: Immunex Corporation
    Inventors: Bruce A. Mosley, David J. Cosman, Linda S. Park, M. Patricia Beckmann, Carl J. March, Rejean Idzerda
  • Publication number: 20030185821
    Abstract: Mammalian Interleukin-4 receptor proteins, DNAs and expression vectors encoding mammalian IL-4 receptors, and processes for producing mammalian IL-4 receptors as products of cell culture, are disclosed. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
    Type: Application
    Filed: March 22, 2002
    Publication date: October 2, 2003
    Applicant: Immunex Corporation
    Inventors: Bruce A. Mosley, David J. Cosman, Linda S. Park, M. Patricia Beckman, Carl J. March, Rejean Idzerda
  • Patent number: 5543320
    Abstract: Mammalian Interleukin-7 receptor proteins, DNAs and expression vectors encoding mammalian IL-7 receptors, antibodies to mammalian Interleukin 7 receptors and processes for producing mammalian IL-7 receptors as products of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: June 25, 1993
    Date of Patent: August 6, 1996
    Assignee: Immunex Corporation
    Inventors: Linda S. Park, Raymond G. Goodwin
  • Patent number: 5298395
    Abstract: Ligand reagents are disclosed which consist essentially of recombinant hyperglycosylated cytokines, expressed in yeast, which are purified and conjugated to various functional moieties, for example, biotin groups, via oligosaccharide residues. Methods of using such ligand reagents are also disclosed.
    Type: Grant
    Filed: November 5, 1992
    Date of Patent: March 29, 1994
    Assignee: Immunex Corporation
    Inventor: Linda S. Park
  • Patent number: 5264416
    Abstract: Mammalian Interleukin-7 receptor proteins, DNAs and expression vectors encoding mammalian IL-7 receptors, and processes for producing mammalian IL-7 receptors as products of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: June 1, 1992
    Date of Patent: November 23, 1993
    Assignee: Immunex Corporation
    Inventors: Linda S. Park, Raymond G. Goodwin
  • Patent number: 5217881
    Abstract: Ligand reagents are disclosed which consist essentially of recombinant hyperglycosylated cytokines, expressed in yeast, which are purified and conjugated to various functional moieties, for example, biotin groups, via oligosaccharide residues.
    Type: Grant
    Filed: January 24, 1992
    Date of Patent: June 8, 1993
    Assignee: Immunex Corporation
    Inventor: Linda S. Park
  • Patent number: 5194375
    Abstract: Mammalian Interleukin-7 receptor proteins, DNAs and expression vectors encoding mammalian IL-7 receptors, and processes for producing mammalian IL-7 receptors as products of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: May 21, 1990
    Date of Patent: March 16, 1993
    Assignee: Immunex Corporation
    Inventors: Linda S. Park, Raymond G. Goodwin
  • Patent number: 5108910
    Abstract: A DNA sequence encoding fusion protein is disclosed which comprises GM-CSF and IL-3. Such fusion proteins more biologically active than GM-CSF or IL-3 alone or GM-CSF and IL-3 combined.
    Type: Grant
    Filed: March 22, 1991
    Date of Patent: April 28, 1992
    Assignee: Immunex Corporation
    Inventors: Benson M. Curtis, Linda S. Park, David J. Cosman
  • Patent number: 5073627
    Abstract: A fusion protein is disclosed which comprises GM-CSF and IL-3. Such fusion proteins more biologically active than GM-CSF or IL-3 alone or GM-CSF and IL-3 combined.
    Type: Grant
    Filed: August 14, 1990
    Date of Patent: December 17, 1991
    Assignee: Immunex Corporation
    Inventors: Benson M. Curtis, Linda S. Park, David J. Cosman